Skip Navigation


ToxSci Advance Access originally published online on September 21, 2005
Toxicological Sciences 2006 89(2):370-379; doi:10.1093/toxsci/kfi332
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Supplementary Data
Right arrow All Versions of this Article:
89/2/370    most recent
kfi332v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (12)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Aleksunes, L. M.
Right arrow Articles by Manautou, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aleksunes, L. M.
Right arrow Articles by Manautou, J. E.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press on behalf of the Society of Toxicology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

HIGHLIGHTED ARTICLE

Coordinated Expression of Multidrug Resistance-Associated Proteins (Mrps) in Mouse Liver during Toxicant-Induced Injury

Lauren M. Aleksunes*, George L. Scheffer{dagger}, Amy B. Jakowski{ddagger}, Ingrid M. Pruimboom-Brees{ddagger} and José E. Manautou*,1

* Department of Pharmaceutical Sciences, University of Connecticut, Storrs, Connecticut 06269; {dagger} Department of Pathology, VU Medical Center, 1081 HV Amsterdam, The Netherlands; and {ddagger} Department of Safety Sciences, Pfizer Global Research and Development, Groton, Connecticut 06340

Received August 9, 2005; accepted September 14, 2005

Following acute chemical injury, hepatocytes are generally more resistant to toxicant re-exposure. Alterations in expression of hepatobiliary transport systems may contribute to this resistance by preventing accumulation of potentially toxic chemicals. Previous data demonstrate the concomitant reduction of uptake transporter and induction of efflux transporter mRNA during chemical liver injury. The present study further characterizes the expression of multidrug resistance-associated proteins 1–4 (Mrp1–4), breast cancer resistance protein (Bcrp) and sodium-taurocholate co-transporting polypeptide (Ntcp) in mouse liver following administration of the hepatotoxicants acetaminophen (APAP) and carbon tetrachloride (CCl4). Mice received hepatotoxic doses of APAP (400 mg/kg), CCl4 (10 or 25 µl/kg), or vehicle, ip. Livers were collected at 6, 24, and 48 h for Western blot quantification and immunofluorescence analysis. Protein expression of Bcrp was unchanged with treatment. Ntcp levels were preserved in APAP-exposed livers and reduced to 30–50% of control after CCl4. Conversely, Mrp1–4 expression was differentially up-regulated. CCl4 increased Mrp1 (3.5-fold), Mrp2 (1.4-fold), and Mrp4 (26-fold) while reducing Mrp3 levels to 20% of control. Administration of APAP enhanced expression of Mrp2 (1.6-fold), Mrp3 (3.5-fold), and Mrp4 (16-fold). Immunostaining of liver sections obtained 48 h after hepatotoxicant treatment confirmed expression patterns of a subset of transporters (Bcrp, Ntcp, Mrp3, and Mrp4). Double immunofluorescence imaging demonstrated the simultaneous down-regulation of Ntcp and up-regulation of Mrp4 in hepatocytes adjacent to the central vein after CCl4. Altered expression of transporters may reduce the overall chemical burden of an injured liver during recovery and contribute to the resistance of hepatocytes to subsequent toxicant exposure.

Key Words: acetaminophen; carbon tetrachloride; hepatotoxicity; Mrp3; Mrp4; Ntcp.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Drug Metab. Dispos.Home page
S. N. Barnes, L. M. Aleksunes, L. Augustine, G. L. Scheffer, M. J. Goedken, A. B. Jakowski, I. M. Pruimboom-Brees, N. J. Cherrington, and J. E. Manautou
Induction of Hepatobiliary Efflux Transporters in Acetaminophen-Induced Acute Liver Failure Cases
Drug Metab. Dispos., October 1, 2007; 35(10): 1963 - 1969.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
K. van de Wetering, N. Zelcer, A. Kuil, W. Feddema, M. Hillebrand, M. L. H. Vlaming, A. H. Schinkel, J. H. Beijnen, and P. Borst
Multidrug Resistance Proteins 2 and 3 Provide Alternative Routes for Hepatic Excretion of Morphine-Glucuronides
Mol. Pharmacol., August 1, 2007; 72(2): 387 - 394.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol PatholHome page
L. M. Aleksunes and J. E. Manautou
Invited Review: Emerging Role of Nrf2 in Protecting Against Hepatic and Gastrointestinal Disease
Toxicol Pathol, June 1, 2007; 35(4): 459 - 473.
[Abstract] [PDF]

Home page
 Mol. Pharmacol.Home page
A. L. Slitt, N. J. Cherrington, M. Z. Dieter, L. M. Aleksunes, G. L. Scheffer, W. Huang, D. D. Moore, and C. D. Klaassen
trans-Stilbene Oxide Induces Expression of Genes Involved in Metabolism and Transport in Mouse Liver via CAR and Nrf2 Transcription Factors
Mol. Pharmacol., May 1, 2006; 69(5): 1554 - 1563.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.